Case Report
Accepted on 07 Nov 2025
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report
in Thoracic Oncology
Frontiers in Oncology
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,871 articles
Original Research
Accepted on 07 Nov 2025
Correlation analysis between EGFR gene mutation status, ALK positivity and demographic data, tumor biomarkers, radiological and pathological features in patients with lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
Original Research
Published on 07 Nov 2025
Predicting immunotherapy response in stage III-IV non-small cell lung cancer using integrated radiomics and clinical features
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1669469
- 270 views
Correction
Published on 07 Nov 2025
Correction: Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1720422
- 163 views
Case Report
Published on 06 Nov 2025
Case Report: Pitfalls in anatomic pathology and clinical oncology: a case of misdiagnosed pulmonary Ewing sarcoma as SCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1635424
- 534 views
Original Research
Published on 06 Nov 2025
Analysis of short-term clinical efficacy and immune function changes of advanced non-small cell lung cancer after radiotherapy or chemotherapy under CT-guided 125I seed implantation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1667205
- 255 views
Original Research
Accepted on 05 Nov 2025
Deciphering the let-7c-5p/RRM2 axis in lung adenocarcinoma: expression, prognosis, and immunelandscape implications
in Thoracic Oncology
Frontiers in Oncology
Systematic Review
Accepted on 04 Nov 2025
Synergistic Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined with Nab-Paclitaxel and Platinum Chemotherapy in NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
in Thoracic Oncology
Frontiers in Oncology
Original Research
Published on 04 Nov 2025
MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1642999
- 294 views
Case Report
Accepted on 03 Nov 2025
Radiation therapy alleviates Doege-Potter syndrome accompanied with severe aortic valve insufficiency: A Case Report and Literature Review
in Thoracic Oncology
Frontiers in Oncology
Case Report
Accepted on 03 Nov 2025
Remarkable response to pembrolizumab in PD-L1 overexpressing (≥50%) NSCLC and extracranial abscopal effect induced by brain radiotherapy: A case report
in Thoracic Oncology
Frontiers in Oncology
Original Research
Accepted on 03 Nov 2025
Prognostic Significance of the Lymphocyte-to-High-Density Lipoprotein Ratio in Long-Term Efficacy of Combined Immunotherapy for Advanced Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
- 160 views
Case Report
Accepted on 03 Nov 2025
CASE REPORT: MUCOEPIDERMOID CARCINOMA OF THE LUNG, A CHALLENGING DIAGNOSIS OF AN UNUSUAL CASE
in Thoracic Oncology
Frontiers in Oncology
Case Report
Accepted on 03 Nov 2025
A Case of Necrotizing Sarcoid Granulomatosis Mimicking Metastatic Tumor
in Thoracic Oncology
Frontiers in Oncology
Original Research
Accepted on 03 Nov 2025
Long-Term Outcomes and Patterns of Failure After Empiric SBRT for Presumed Early-Stage Lung Tumors
in Thoracic Oncology
Frontiers in Oncology
Original Research
Accepted on 31 Oct 2025
CD26 as a potential therapeutic target for lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
- 162 views